您的位置: 首页 > 农业专利 > 详情页

Heterocyclic spiro compounds as MAGL inhibitors
专利权人:
Pfizer Inc.
发明人:
Brodney, Michael Aaron,Butler, Christopher Ryan,Helal, Christopher John,McAllister, Laura Ann,O'Neil, Steven Victor,Verhoest, Patrick Robert
申请号:
AU2018208848
公开号:
AU2018208848A1
申请日:
2018.01.09
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The present invention provides, in part, heterocyclic spiro compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充